Treatment with tirzepatide in adults with pre-diabetes and obesity or ...
Nov 13, 2024About SURMOUNT-1 SURMOUNT-1 (NCT04184622) was a multi-center, randomized, double-blind, parallel, placebo-controlled trial comparing the efficacy and safety of tirzepatide 5 mg, 10 mg and 15 mg to placebo as an adjunct to a reduced-caloriedietand increased physical activity in adults without type 2diabeteswho had obesity, or overweight with at least one of the following comorbidities ...
source: https://investor.lilly.com